Modified antibody

Details for Australian Patent Application No. 2004215489 (hide)

Owner Vaccibody AS

Inventors Fredriksen, Agnete Brunsvik; Bogen, Bjarne; Sandlie, Inger

Agent Fisher Adams Kelly

Pub. Number AU-B-2004215489

PCT Pub. Number WO2004/076489

Priority 10/786,907 25.02.04 US; 60/450,134 25.02.03 US

Filing date 25 February 2004

Wipo publication date 10 September 2004

Acceptance publication date 15 July 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/44 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material not provided for elsewhere

Event Publications

8 September 2005 PCT application entered the National Phase

  PCT publication WO2004/076489 Priority application(s): WO2004/076489

22 March 2007 Assignment before Grant

  Medinnova AS The application has been assigned to Vaccibody AS

15 July 2010 Application Accepted

  Published as AU-B-2004215489

11 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004215491-Connection device

2004215481-Pyrazolo(1,5-A)pyrimidine derivatives